New Benchmarks on Protocol Amendment Practices, Trends and their Impact on Clinical Trial Performance.
The Tufts Center for the Study of Drug Development (Tufts CSDD) conducted a follow-up study in 2022 to assess trends in protocol amendment experiences and the impact amendments have had on clinical trial performance, particularly during the COVID-19 pandemic. Sixteen pharmaceutical companies and con...
| Published in: | Therapeutic Innovation & Regulatory Science Vol. 58; no. 3; pp. 539 - 549 |
|---|---|
| Main Authors: | , , , , |
| Format: | research tables/charts Journal Article |
| Published: |
Springer Nature
May2024
|
| Online Access: | View this record in EBSCOhost |